Adalimumab, Infliximab And Etanercept Biosimilars Global Market Report 2023: Increasing Healthcare Access Bolsters Sector
January 11, 2023 04:48 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ...
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: Featuring Zydus Cadila, Abbvie, Samsung Bioepis & More
November 18, 2022 08:08 ET
|
Research and Markets
Dublin, Nov. 18, 2022 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2022: By Product, By Application, By Distribution" report has been added to ...
Worldwide Reiter's Syndrome Treatment Industry to 2027 - by Drug Type, Dosage Form, Route of Administration, Distribution Channel, End-user and Region
September 28, 2022 06:38 ET
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Reiter's Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027" report has been added to ...
China Infliximab Market Investigation Report 2022: Sales 2017-2021, Major Manufacturers 2017-2021, Prices for Different Manufacturers 2021-2022 and Prospects 2022-2031
August 10, 2022 05:28 ET
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2022-2031" report has been added to ResearchAndMarkets.com's offering. According to this market...
Global Graft Versus Host Disease (GvHD) Treatment Market Report 2022: Corticosteroids Accounted for More than 28.97% Share Due to Wide Recommendation in Frontline Setting
June 06, 2022 05:48 ET
|
Research and Markets
Dublin, June 06, 2022 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has been added to...
The Worldwide Organ Transplantation Industry is Expected to Reach $22.1 Billion by 2026
February 18, 2022 08:14 ET
|
Research and Markets
Dublin, Feb. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplantation Market (2021-2026) by Treatment, Organ, Product, Transplant, End User, Geography, Competitive Analysis and the Impact of...
Global GVHD Market Landscape Report, 2030: Epidemiology, Emerging Drugs, Market Shares of Therapies, Drivers & Barriers, Unmet Needs, Major Players & SWOT Analysis
December 21, 2021 08:33 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering....
HUMIRA (Adalimumab) Biosimilars Market Report 2021: Current Developer Landscape and Clinical Research Scenario Related to All the Follow-on Products of the Blockbuster Biologic Drug
July 30, 2021 06:03 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "HUMIRA? (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
China's Infliximab Markets, 2016-2020 & 2021-2025 - Relevant Concepts, Sales, Major Manufacturers, Prices, Prospects
July 29, 2021 08:33 ET
|
Research and Markets
Dublin, July 29, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Infliximab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Infliximab is a human-mouse...
Global Corticosteroids Market Report 2021 Featuring Major Players - Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Cipla, and LEO Pharma
May 13, 2021 04:53 ET
|
Research and Markets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Corticosteroids Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. Major...